publication venue for
- Evaluating mFARS in pediatric Friedreich's ataxia: Insights from the FACHILD study.. 11:1290-1300. 2024
- Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort.. 11:1110-1121. 2024
- Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease.. 11:673-685. 2024
- Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data.. 11:4-16. 2023
- A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment.. 10:1738-1748. 2023
- Automated detection of immune effector cell-associated neurotoxicity syndrome via quantitative EEG.. 10:1776-1789. 2023
- Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia.. 10:1397-1406. 2023
- Vascular endothelial-cadherin as a marker of endothelial injury in preclinical Alzheimer disease.. 9:1926-1940. 2022
- Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network.. 9:1727-1738. 2022
- Comparison of plasma and CSF biomarkers in predicting cognitive decline.. 9:1739-1751. 2022
- A population-based meta-analysis of circulating GFAP for cognition and dementia risk.. 9:1574-1585. 2022
- Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease.. 9:756-761. 2022
- Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers.. 9:155-170. 2022
- Digital endpoints for self-administered home-based functional assessment in pediatric Friedreich's ataxia.. 8:1845-1856. 2021
- Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort.. 8:1239-1250. 2021
- Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy.. 8:1086-1095. 2021
- Flortaucipir (tau) PET in LGI1 antibody encephalitis.. 8:491-497. 2021
- Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features.. 8:224-237. 2020
- Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease.. 7:2475-2480. 2020
- Test-retest reliability of the Friedreich's ataxia rating scale.. 7:1708-1712. 2020
- The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults.. 7:776-785. 2020
- MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous.. 7:707-721. 2020
- Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD).. 8:308-320. 2020
- Impaired cognition predicts the risk of hospitalization and death in cirrhosis.. 6:2282-2290. 2019
- Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.. 6:1757-1770. 2019
- Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.. 6:1423-1434. 2019
- γ. 6:546-553. 2019
- Plasma urate concentrations and possible REM sleep behavior disorder.. 6:2368-2376. 2019
- Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.. 6:15-26. 2018
- Monoclonal antibodies from a patient with anti-NMDA receptor encephalitis.. 5:935-951. 2018
- Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis.. 5:1522-1533. 2018
- NMNAT3 is protective against the effects of neonatal cerebral hypoxia-ischemia.. 4:722-738. 2017
- Impact of diabetes in the Friedreich ataxia clinical outcome measures study.. 4:622-631. 2017
- Selected missense mutations impair frataxin processing in Friedreich ataxia.. 4:575-584. 2017
- β. 4:284-291. 2017
- Altered sleep and EEG power in the P301S Tau transgenic mouse model.. 4:180-190. 2017
- MC1R. 4:212-216. 2017
- Age-dependent effects of APOE ε4 in preclinical Alzheimer's disease.. 3:668-77. 2016
- Progression of Friedreich ataxia: quantitative characterization over 5 years.. 3:684-94. 2016
- Deep sequencing of mitochondrial genomes reveals increased mutation load in Friedreich's ataxia.. 3:523-36. 2016
- Nmnat1 protects neuronal function without altering phospho-tau pathology in a mouse model of tauopathy.. 3:434-42. 2016
- Frataxin levels in peripheral tissue in Friedreich ataxia.. 2:831-42. 2015
- Cardiorespiratory fitness is associated with white matter integrity in aging.. 2:688-98. 2015
- Anti-tau antibody reduces insoluble tau and decreases brain atrophy.. 2:278-88. 2015
- Pediatric anti-NMDA receptor encephalitis is seasonal.. 1:921-5. 2014
- High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.. 1:822-32. 2014
- Disease-Modifying Effect of Adiponectin in Model of α-Synucleinopathies.. 1:479-489. 2014
- Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis.. 1:180-189. 2014
- Preoperative cerebrospinal fluid β-Amyloid/Tau ratio and postoperative delirium.. 1:319-328. 2014